The outlook and analysis of Neuronetics Inc (STIM)’s stock

Ulysses Smith

At the time of writing, Neuronetics Inc [STIM] stock is trading at $1.81, up 7.10%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The STIM shares have gain 28.37% over the last week, with a monthly amount glided 34.07%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Neuronetics Inc [NASDAQ: STIM] stock has seen the most recent analyst activity on August 13, 2024, when William Blair downgraded its rating to a Mkt Perform. Previously, William Blair downgraded its rating to Mkt Perform on October 13, 2021. On October 13, 2021, downgrade downgraded it’s rating to Neutral. William Blair upgraded its rating to an Outperform. BTIG Research initiated its recommendation with a Buy and recommended $11 as its price target on February 06, 2020.

For the past year, the stock price of Neuronetics Inc fluctuated between $1.25 and $5.92. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Neuronetics Inc [NASDAQ: STIM] shares were valued at $1.81 at the most recent close of the market. An investor can expect a potential return of 341.99% based on the average STIM price forecast.

Analyzing the STIM fundamentals

According to Neuronetics Inc [NASDAQ:STIM], the company’s sales were 129.87M for trailing twelve months, which represents an 101.28% jump. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.29%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -1.51 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.32.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6441 points at the first support level, and at 1.4783 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9229, and for the 2nd resistance point, it is at 2.0359.

Ratios To Look Out For

It is important to note that Neuronetics Inc [NASDAQ:STIM] has a current ratio of 2.24. Further, the Quick Ratio stands at 2.09, while the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 0.95, the price to book ratio is 4.53.

Transactions by insiders

Recent insider trading involved Madryn Asset Management, LP, 10% Owner, that happened on Aug 08 ’25 when 3.5 million shares were sold. 10% Owner, MADRYN HEALTH PRTS II (CAY MAS completed a deal on Aug 08 ’25 to buy 2.93 million shares. Meanwhile, 10% Owner MADRYN HEALTH PARTNERS II, LP bought 0.19 million shares on Aug 08 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.